| Literature DB >> 22815773 |
Josue Moura Romao1, Weiwu Jin, Maolong He, Tim McAllister, Le Luo Guan.
Abstract
BACKGROUND: MicroRNAs (miRNAs) are a class of molecular regulators found to participate in numerous biological processes, including adipogenesis in mammals. This study aimed to evaluate the differences of miRNA expression between bovine subcutaneous (backfat) and visceral fat depots (perirenal fat) and the dietary effect on miRNA expression in these fat tissues. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2012 PMID: 22815773 PMCID: PMC3398999 DOI: 10.1371/journal.pone.0040605
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Performance and fat traits of animals fed control or high fat diet.
| Control | High fat | ||
| Performance andfat traits | Mean ± SD | Mean ± SD | p-value |
| Weight gain (kg) | 151.70±20.69 | 181.40±24.06 | 0.018 |
| Feed Conversion Rate | 5.76±0.51 | 5.20±0.30 | 0.019 |
| Cutability (%) | 53.25±2.66 | 51.13±1.64 | 0.075 |
| Backfat thickness (mm) | 17.62±5.01 | 20.75±3.54 | 0.171 |
| Adipocyte size (µm) | 134.71±8.95 | 146.50±13.78 | 0.062 |
Adipocytes used for analysis were derived from backfat tissue.
miRNAs detected by individual and average according to diet and fat tissue.
| Control diet | High fat diet | ||||
| ID | Subcutaneous fat | Visceralfat | ID | Subcutaneous fat | Visceralfat |
| C108 | 159 | 126 | F103 | 163 | 162 |
| C111 | 131 | 115 | F109 | 162 | 163 |
| C209 | 162 | 124 | F202 | 162 | 163 |
| C211 | 160 | 153 | F204 | 162 | 162 |
| C307 | 160 | 129 | F302 | 163 | 163 |
| C308 | 142 | 128 | F303 | 163 | 162 |
| C405 | 118 | 161 | F411 | 162 | 163 |
| C410 | 159 | 162 | F412 | 163 | 163 |
| Avg. | 148.8±16.6b | 137.2±18.4b | 162.5±0.5a | 162.6±0.5a | |
different letters mean significant difference between diet or fat depot comparisons, p<0.05.
Figure 1Distribution of miRNAs detected in steers fed control diet (A) or high fat diet (B). The distribution of miRNAs considers data from both subcutaneous and visceral fat tissue for Control (A) and High fat diet (B) groups. Each pie chart represents how the total amount of miRNAs (Control = 207, High fat = 206) are distributed within the animal population of each group, varying from a maximum of eight out of eight animals to a minimum of one out of eight.
Figure 2Expression of miRNAs by qRT-PCR and microarray.
MicroRNA expression is presented for the following treatments on the horizontal axis: Control diet/Subcutaneous fat (C/Scf), High fat diet/Subcutaneous fat (HF/Scf), Control diet/Visceral fat (C/Vf) and High fat diet/Visceral fat (HF/Vf). The graphs show the miRNA expression from miRNA microarray represented by lines (–○–) on the top and values are shown on the left vertical axis as normalized intensity values. Quantitative PCR expression is represented using columns (←) on the bottom and values are shown on the right vertical axis as delta cycle threshold (ΔCt). A, B, C, D Columns (qPCR) with different letters differ significantly (p<0.05). a, b, c Markers in lines (microarray) with different letters differ significantly (p<0.05). Data are presented as Mean ± Standard deviation.
Predicted miRNA gene targets with functions related to lipid metabolism and/or adipogenesis.
| microRNA | Symbol | Entrez Gene Name |
| bta-miR-16b | FGF2 | fibroblast growth factor 2 (basic) |
| GNAI3 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 | |
| LRP6 | low density lipoprotein receptor-related protein 6 | |
| PAFAH1B2 | platelet-activating factor acetylhydrolase 1b,catalytic subunit 2 (30 kDa) | |
| SMAD7 | SMAD family member 7 | |
| WNT3A | wingless-type MMTV integration site family, member 3A | |
| bta-miR-19a | SOCS3 | suppressor of cytokine signaling 3 |
| SGK1 | serum/glucocorticoid regulated kinase 1 | |
| ADRB1 | adrenergic, beta-1-, receptor | |
| ABHD5 | abhydrolase domain containing 5 | |
| bta-miR-92a,b | ADRB1 | adrenergic, beta-1-, receptor |
| TEF | thyrotrophic embryonic factor | |
| bta-miR-101 | SLC12A2 | solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
| SGK1 | serum/glucocorticoid regulated kinase 1 | |
| PRKCE | protein kinase C, epsilon | |
| PPARGC1B | peroxisome proliferator-activated receptor gamma, coactivator 1 beta | |
| KITLG | KIT ligand | |
| GSK3B | glycogen synthase kinase 3 beta | |
| APP | amyloid beta (A4) precursor protein | |
| bta-miR-103 | BDNF | brain-derived neurotrophic factor |
| CLOCK | clock homolog (mouse) | |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | |
| bta-miR-106 | ABHD5 | abhydrolase domain containing 5 |
| REST | RE1-silencing transcription factor | |
| bta-mi-142–5p | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
| ACSL6 | acyl-CoA synthetase long-chain family member 6 | |
| CAV2 | caveolin 2 | |
| REST | RE1-silencing transcription factor | |
| bta-miR-196a | GLTP | glycolipid transfer protein |
| bta-miR-296 | ABHD4 | abhydrolase domain containing 4 |
| PPARGC1B | peroxisome proliferator-activated receptor gamma, coactivator 1 beta | |
| bta-miR-2368* | ACSL3 | acyl-CoA synthetase long-chain family member 3 |
| CARM1 | coactivator-associated arginine methyltransferase 1 | |
| CLOCK | clock homolog (mouse) | |
| FOXO1 | forkhead box O1 | |
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | |
| PPARA | peroxisome proliferator-activated receptor alpha | |
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | |
| bta-miR-2454 | B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
| PDGFB | platelet-derived growth factor beta polypeptide |
Functional analysis of gene targets involved in lipid metabolism and adipogenesis.
| Category | Function | Pathways | p-value | Predicted gene targets involved |
| Lipid Metabolism | synthesis | synthesis of lipid | 2.15E-15 | ABCA1, ABHD5, ACSL3, ACSL6, APP, B4GALT1, BDNF, CAV2, FGF2, FOXO1, GNAI3, KITLG, LIF, PDGFB, PPARA, PTGS2, REST, SNCA, SOCS3 |
| synthesis of phospholipid | 1.68E-06 | ABHD5, ACSL6, FGF2, PDGFB, PTGS2, SOCS3 | ||
| synthesis of fatty acid | 2.07E-06 | ABCA1, ACSL3, APP, CAV2, KITLG, LIF, PTGS2, SNCA | ||
| synthesis of steroid | 3.27E-06 | APP, BDNF, FGF2, KITLG, LIF, PPARA, REST | ||
| metabolism | metabolism of membrane lipid derivative | 7.67E-13 | ABCA1, ABHD5, ACSL6, APP, B4GALT1, BDNF, FGF2, GNAI3, KITLG, PDGFB, PTGS2, SNCA, SOCS3 | |
| fatty acid metabolism | 3.81E-12 | ABCA1, ACSL3, ACSL6, APP, B4GALT1, CAV2, FGF2, GLTP, GNAI3, KITLG, LIF, PPARA, PTGS2, SNCA, TEF | ||
| metabolism of phospholipid | 3.44E-07 | ABHD5, ACSL6, FGF2, PDGFB, PTGS2, SNCA, SOCS3 | ||
| metabolism of acylglycerol | 5.68E-06 | ABHD5, ACSL6, FOXO1, GNAI3, KITLG | ||
| quantity | quantity of lipid | 3.73E-11 | ABCA1, ADRB1, APP, B4GALT1, BDNF, FOXO1, KITLG, LIF, PPARA, PPARGC1B, PRKCE, PTGS2, SGK1, SLC12A2, SNCA | |
| quantity of steroid | 5.85E-10 | ABCA1, ADRB1, APP, BDNF, LIF, PPARA, PPARGC1B, PRKCE, PTGS2, SGK1, SLC12A2 | ||
| quantity of triacylglycerol | 5.39E-06 | BDNF, FOXO1 (includes EG:2308), PPARA, PPARGC1B, PRKCE, PTGS2 | ||
| quantity of sterol | 7.10E-06 | ABCA1, APP, BDNF, PPARA, PPARGC1B, PTGS2 | ||
| oxidation | oxidation of lipid | 2.84E-08 | ABHD5, ACSL3, ACSL6, APP, PPARA, PPARGC1B, PTGS2, SNCA | |
| oxidation of fatty acid | 1.84E-06 | ABHD5, ACSL3, ACSL6, PPARA, PPARGC1B, PTGS2 | ||
| oxidation of oleic acid | 3.36E-06 | ACSL3, ACSL6, PPARA | ||
| accumulation | accumulation of lipid | 2.47E-07 | ABCA1, ABHD5, ACSL6, APP, FOXO1, GSK3B, PAFAH1B2, PPARA | |
| release | release of lipid | 2.97E-07 | ABCA1, APP, CAV2, GNAI3, KITLG, PDGFB, PRKCE, PTGS2 | |
| release of fatty acid | 1.32E-05 | CAV2, GNAI3, KITLG, PDGFB, PRKCE, PTGS2 | ||
| cleavage | cleavage of lipid | 3.36E-07 | ABHD4, ABHD5, GNAI3, PAFAH1B2, PPARA, PTGS2, SNCA | |
| biosynthesis | biosynthesis of glycosphingolipid | 2.25E-06 | APP, B4GALT1, FGF2, GNAI3, KITLG | |
| concentration | concentration of lipid | 3.89E-06 | ABCA1, APP, CLOCK, PPARA, PTGS2 | |
| hydrolysis | hydrolysis of lipid | 4.63E-06 | ABHD4, ABHD5, GNAI3, PAFAH1B2, PPARA, SNCA | |
| esterification | esterification of lipid | 5.68E-06 | ABCA1, APP, LIF, PPARA | |
| steroidogenesis | steroidogenesis | 1.39E-05 | APP, BDNF, FGF2, KITLG, LIF, PPARA | |
| Connective Tissue Development and Function | differentiation | differentiation of adipocytes | 1.28E-10 | ADRB1, CARM1, FOXO1 (includes EG:2308), GSK3B, LIF, LRP6, PPARA, SMAD7, WNT3A |
Formulation of Control and High fat diets.
| Feed Formulation | Control | High fat |
| Barley grain, % | 85.00 | 75.00 |
| Barley silage (ave 160), % | 10.00 | 10.00 |
| Vitamin & mineral supplement, % | 5.00 | 5.00 |
| Flax seed, % | 0.00 | 10.00 |
Containing the following minerals and vitamin in 1 kg: 14.67 mg copper, 58.32 mg zinc, 26.73 mg manganese, 0.66 mg iodine, 0.23 mg cobalt, 0.29 mg selenium, 4825 IU vitamin A, 478 IU vitamin D and 32 IU vitamin E.
Nutritional composition of Control and High fat diets.
| Composition | Control | High fat |
| Dry Matter, % | 73.93 | 74.67 |
| Protein, % | 12.71 | 13.81 |
| Degr. CH2O | 47.60 | 42.00 |
| NEm, Mcal/kg | 1.98 | 2.00 |
| NEg, Mcal/kg | 1.33 | 1.34 |
| Calcium, % | 0.62 | 0.64 |
| Fat, % | 1.95 | 5.85 |
Degradable carbohydrates.
Net energy for maintenance.
Net energy for gain.